During the past decade, Polyclinique Saint Laurent conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique Saint Laurent" #1 sponsor was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials, followed by "ResMed" with 2 trials sponsored, "Biotronik AG" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored and "Groupe Medical de Pneumologie, Polyclinique Saint-Laurent" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique Saint Laurent" #1 collaborator was "Biotronik France" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "EVAMED" with 1 trials as a collaborator, "ICUREsearch" with 1 trials as a collaborator and "Regional Health Agency - Brittany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique Saint Laurent" are "Obstructive Sleep Apnea" (4 trials), "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Brady-Tachy Syndrome" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "Polyclinique Saint Laurent" in a lesser frequency.

Most popular intervention types in "Polyclinique Saint Laurent" are "Device" (8 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blephasteam" (1 trials), "CSR remote monitoring" (1 trials), "Cobalt-Chromium Bare Metal Stents" (1 trials), "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials) and "Genio(TM) system therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Saint Laurent" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Polyclinique Saint Laurent". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Polyclinique Saint Laurent, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Saint Laurent, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".